The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
IsoPlexis Corp(NASDAQ:ISO) 
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-t...
Website: http://isoplexis.com
Founded: 2013
CEO: Sean Mackay
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
IsoPlexis Corp Days Payable Outstanding ttm (DPO)
IsoPlexis Corp Days Receivable Outstanding ttm (DSO)
IsoPlexis Corp Days Inventory Outstanding ttm (DIO)
IsoPlexis Corp Op Cashflow Per Share ttm
IsoPlexis Corp Free Cashflow Per Share ttm
IsoPlexis Corp Cash Per Share ttm
IsoPlexis Corp P/S ratio ttm
IsoPlexis Corp (GAAP) P/E ratio ttm
IsoPlexis Corp P/B ratio ttm
No extra charts and metrics for this ticker.